The flow chemistry market size is projected to grow from USD 1.7 billion in 2022 to USD 2.9 billion by 2028, registering a CAGR of 10.4% during the forecast period. This growth is attributed to the increasing demand for efficient and sustainable chemical manufacturing processes, as well as the growing interest in the synthesis of complex molecules, such as pharmaceutical intermediates and specialty chemicals, further fuels the demand for flow chemistry. The pharmaceutical industry is a significant driver of flow chemistry adoption. The increasing demand for new drug candidates, coupled with the need for efficient and cost-effective synthesis methods, has fueled the use of flow chemistry in pharmaceutical manufacturing. Flow chemistry enables streamlined synthesis routes, rapid optimization, and improved yield and purity of pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1316
Flow Chemistry Market Trending key Players
Players have adopted different strategies to strengthen their market positions and ensure long-term growth and success. These strategies enable them to efficiently meet the growing demand for reactor’s and purification method by various industries. Also, companies operating in this market, such as Thermo Fisher Scientific Inc (US), Corning Incorporated (US), Lonza (Switzerland), PerkinElmer Inc (US), Biotage (Sweden), adopt acquisitions, new product launch, agreement, expansions, collaborations, and partnerships to increase their market shares and expand their geographic presence.
Thermo Fisher Scientific (US) is a global leader in the life sciences business, with annual revenue of more than $44 billion and a diverse variety of products and services that enable scientific study and discovery across a wide range of applications. With its strong regional presence and expertise in flow chemistry, the company is well-positioned to continue its expansion and success in the years ahead. It offers a variety of goods and services to customers in the pharmaceutical, biotechnology, academic, and government sectors. Thermo Electron Corporation and Fisher Scientific International merged to form the company in 2006, and it has since evolved to become a leading provider of scientific research products and services globally. Thermo Fisher Scientific offers a comprehensive range of products and services, including laboratory equipment and supplies, analytical instruments, reagents and consumables, software and services, and specialist diagnostics. The company's products are used in a wide range of applications, including drug discovery and development, clinical research, and environmental studies. Thermo Fisher Scientific has a substantial presence in North America, Europe, and Asia, and operates in over 50 countries globally. The company has a global network of sales and service personnel, as well as production and distribution facilities, allowing it to serve consumers in practically every country.
Get Sample Copy of this Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1316
Lonza (Switzerland) is a multi-national contract development and manufacturing organization (CDMO) that serves specialty ingredients, biotechnology, and pharmaceutical industries. Pharma Biotech & Nutrition, Specialty Ingredients, and Capsules & Health Ingredients are the three primary business divisions of the organization. The Pharma Biotech & Nutrition segment offers products and services to the pharmaceutical and biotech sectors, including the development and production of drug substances, manufacturing of cell and gene therapies, formulation development, and biomanufacturing. Supplements like probiotics and vitamins are also available in this area, along with other food-related goods and services. Lonza has operations in Switzerland, Germany, Spain, the UK, and other nations. The company is headquartered in Basel, Switzerland, and it has a sizable presence throughout Europe. Lonza is a manufacturer with facilities and offices in both the US and Canada. With locations in China, Japan, and Singapore among other nations, the corporation is also expanding its influence in Asia. Lonza was established in 1897 in the Swiss Alps and now operates on five continents. Lonza generated revenues of CHF 6.2 billion with a CORE EBITDA of CHF 2.0 billion in the full year 2022 with over 17,500 full-time employees. The Lonza shares are traded on the Swiss Market Index (SMI) and SIX Swiss Exchange. Additionally, it keeps a secondary listing on the Singapore Exchange (SGX).
Corning Incorporated (US) is a materials science innovator. Corning has been developing category-defining products that alter industries and improve people's lives for more than 170 years, combining unrivaled expertise in glass science, ceramic science, and optical physics with deep production and engineering capabilities. Corning's Life Sciences sector, which has been a major creator, manufacturer, and global supplier of laboratory goods for over 100 years, works with researchers and medication manufacturers to boost efficiencies, reduce costs, and shorten timeframes. The division provides new solutions that boost productivity and enable breakthrough research by leveraging its unique knowledge in the domains of materials science, polymer surface science, cell culture, and biology. Globally, the items are marketed to pharmaceutical and biotechnology businesses, academic institutions, hospitals, government entities, and other facilities, largely through distributors. Corning manufactures these items in the United States in Illinois, Maine, Massachusetts, New York, North Carolina, Utah, and Virginia, as well as in China, France, Mexico, and Poland, and outside the United States in China, France, Mexico, and Poland.
PerkinElmer Inc. (US) is a multinational firm that produces innovative solutions for diagnostics, life sciences, and application sectors. The company provides a diverse range of products and services that appeal to industries such as pharmaceuticals, biotechnology, environmental, food, and beverage, among others. PerkinElmer has a broad geographic presence, with operations in over 150 countries globally. The company has a global sales and service network, with over 12,000 personnel working in various locations such as North America, Europe, Asia Pacific, and Latin America. PerkinElmer maintains a strong focus on innovation and has made major expenditures in research and development, with a portfolio of over 13,000 patents and patent applications globally. The company is known for creating cutting-edge technologies and solutions that assist customers to enhance their productivity, efficiency, and profitability. PerkinElmer is a significant player in the flow chemistry market, offering a wide range of goods and services for flow chemistry applications, including instruments, consumables, software, and services.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1316
Pharmaceutical synthesis, by application, is expected to be the most significant Flow chemistry segment during the forecast period.
The pharmaceutical synthesis segment is expected to be the most significant in the flow chemistry market during the forecast period due to the high demand for efficient manufacturing processes, scalability, improved safety, the complexity of pharmaceutical molecules, and sustainability requirements in the pharmaceutical industry. Stringent regulations and the need for sustainable practices in the pharmaceutical industry further contribute to the significance of pharmaceutical synthesis in the flow chemistry market.
The microreactor is anticipated to be the fastest-growing Flow chemistry segment, by the reactor, during the forecast period.
The microreactor segment is anticipated to be the fastest-growing flow chemistry segment by reactor during the forecast period, due to the pharmaceutical industry, which is a significant consumer of flow chemistry, is increasingly adopting microreactors for drug synthesis and production. The pharmaceutical industry often requires the synthesis of complex molecules and the optimization of reaction conditions to achieve high purity and yield. Microreactors facilitate the synthesis of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) by providing excellent control over reaction parameters, enhancing productivity, and enabling rapid process optimization.
Asia Pacific is expected to be the largest segment in the global Flow chemistry market, by region, during the forecast period.
Asia Pacific region is experiencing the largest market share in the flow chemistry market due to the region has been witnessing significant economic growth and industrial development in countries such as China, India, Japan, South Korea, and Singapore. Asia Pacific region is home to a large number of pharmaceutical, chemical, and petrochemical companies, which are major consumers of flow chemistry systems.
